Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2015

Mar 31, 2015

33869_rns_2015-03-31_b5322e05-0cf6-4649-9eed-cc3c9c23c160.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX ANNOUNCEMENT

NOTICE UNDER SECTION 708A(5)(e) OF THE CORPORATIONS ACT

  • 1 April 2015

On 20 March 2015, Admedus Limited (ASX:AHZ) ( Company ) announced the successful placement to institutional and sophisticated investors to raise approximately $12 million through the private placement of ordinary shares at an issue price of $0.07. Settlement of the issue of: (i) 170,075,000 shares took place on 25 March 2015; and (ii) 1,425,000 shares took place on 1 April 2015.

In addition, on 25 March 2015 the Company announced that 333,333 shares had been issued on 24 March 2015 upon the clearing of receipts totalling $19,999.98 on exercise of 333,333 options exercisable at $0.06.

The Company advises that the Corporations Act ( Act ) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under the section 708 or 708A. By the Company giving this notice, a sale of the shares noted above will fall within the exemption in section 708A(5) of the Act.

The Company hereby notifies ASX under paragraph 708A(5)(e) of the Act that:

  1. the Company issued the securities without disclosure to investors under Part 6D.2 of the Act;

  2. as at the date of this notice, the Company has complied with the provisions of Chapter 2M of the Act as they apply to the Company, and section 674 of the Act; and

  3. as at the date of this notice, there is no information that is excluded information under section 708A(7) and (8) of the Act that has not already been disclosed to investors generally.

Yours faithfully

Stephen Mann Company Secretary

==> picture [595 x 44] intentionally omitted <==